Riluzole in Spinal Cord Injury Study (RISCIS)–Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial-Reference-Cited by-同舟云学术

Riluzole in Spinal Cord Injury Study (RISCIS)–Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial

Published:2023-09-01 Issue:17-18 Volume:40 Page:1889-1906
ISSN:0897-7151
Container-title:Journal of Neurotrauma
language:en
Short-container-title:Journal of Neurotrauma

Author:

Chow Diana Shu-Lian¹,Nguyen Ashley¹²,Park Junghwa¹,Wu Lei¹³,Toups Elizabeth Gardiner⁴,Harrop James Shields⁵,Guest James David⁶,Schmitt Karl Michael⁷,Aarabi Bizhan⁸,Fehlings Michael George⁹,Boakye Maxwell¹⁰,Grossman Robert Geroge⁴

Affiliation:

1. Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA.

2. Janssen Pharmaceutical Companies of Johnson & Johnson, Philadelphia, Pennsylvania, USA.

3. AbbVie Pharmaceuticals, Chicago, Illinois, USA.

4. Department of Neurosurgery, Houston Methodist Research Institute, Houston, Texas, USA.

5. Department of Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

6. Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.

7. Department of Neurosurgery, Health Science Center, University of Texas, Houston, Texas, USA.

8. Department of Neurosurgery, University of Maryland, Baltimore, Maryland, USA.

9. Division of Neurosurgery and Spine Program, Toronto Western Hospital, University of Toronto, Ontario, Canada.

10. Department of Neurosurgery, University of Louisville, Louisville, Kentucky, USA.

Publisher

Mary Ann Liebert Inc

Subject

Neurology (clinical)

Link

https://www.liebertpub.com/doi/pdf/10.1089/neu.2022.0499

Reference34 articles.

1. The leading edge: Emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injury

2. Guidelines for the Management of Acute Cervical Spine and Spinal Cord Injuries

3. A Clinical Practice Guideline for the Management of Acute Spinal Cord Injury: Introduction, Rationale, and Scope

4. A Review of Clinical Trials in Spinal Cord Injury Including Biomarkers

5. The pharmacology and mechanism of action of riluzole

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Systems Medicine Approach to Spinal Cord Injury;Journal of Neurotrauma;2023-09-01

2. Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial;Journal of Neurotrauma;2023-09-01